November 5, 2025 — Leads & Copy — Verastem Oncology (Nasdaq: VSTM) will participate and present at two investor conferences in November, including the Guggenheim Healthcare Conference on November 11 at 1:00 pm ET and the Jefferies Global Healthcare Conference in London on November 19 at 2:30 pm GMT (9:30 am ET). Live webcasts will be available in the investor section of Verastem’s website, with replays archived for 90 days.
Verastem Oncology is focused on creating new medicines for RAS/MAPK pathway-driven cancers and markets AVMAPKI™ FAKZYNJA™ CO-PACK in the U.S. The company’s pipeline includes small molecule drugs that inhibit critical signaling pathways in cancer, promoting cell survival and tumor growth.
Source: Verastem Oncology Verastem Oncology
